Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 30, Issue 10, October 2005, Pages 985-1076
 
MONOGRAPHS
 
  
 Asoprisnil.
Endometriosis therapy, Treatment of uterine fibroids, Selective progesterone receptor modulator.
Cole, P., Castaner, J., Fernandez, D.
Drugs Fut 2005, 30(10): 985
Summary | Full Text: HTMLPDF 
 
  
  
 Bifeprunox Mesilate.
Treatment of bipolar disorder, Treatment of schizophrenia, Dopamine D2 receptor partial agonist, 5-HT1A receptor agonist.
Sorbera, L.A., Castaner, J.
Drugs Fut 2005, 30(10): 992
Summary | Full Text: HTMLPDF 
 
  
  
 PCK-3145.
Prostate cancer therapy.
Rabbani, S.A., Shukeir, N., Garde,S., Wu, J.J., Panchal, C.
Drugs Fut 2005, 30(10): 998
Summary | Full Text: HTMLPDF 
 
  
  
 PEP-005.
Treatment of actinic keratoses, Acute myeloid leukemia therapy, Treatment of basal cell carcinoma, Protein kinase C activator.
Hampson, P., Wang, K., Lord, J.M.
Drugs Fut 2005, 30(10): 1003
Summary | Full Text: HTMLPDF 
 
  
  
 TH-9507.
Treatment of AIDS-associated lipodystrophy, Treatment of cachexia, Growth hormone-releasing factor analogue.
Sorbera, L.A., Castaner, J., Leeson, P.A.
Drugs Fut 2005, 30(10): 1006
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 Bispecific antibodies as emerging pharmaceuticals for tumor immunotherapy.
Aramwit, P., Liu, X., Cong, X., Lam, L., Cao, Y.
Drugs Fut 2005, 30(10): 1013
Summary | Full Text: HTMLPDF 
 
  
  
 Current status of gene therapy for lung cancer.
Vattemi, E., Claudio, P.P.
Drugs Fut 2005, 30(10): 1017
Summary | Full Text: HTMLPDF 
 
  
  
 MV-6401, a potent photosensitizer in experimental animal models: a review of this agent and the current state of photosensitizing agents for the treatment of exudative age-related macular degeneration.
Ciulla, T.A., Oliver, A., Comer, G.M.
Drugs Fut 2005, 30(10): 1031
Summary | Full Text: HTMLPDF 
 
  
  
 New agents for imaging the cardiac nervous system?.
Pauwels, E.K.J., Arkies, H.
Drugs Fut 2005, 30(10): 1039
Summary | Full Text: HTMLPDF 
 
  
  
 Recent advances in antiangiogenesis strategies.
Mousa, S.A., Mousa, A.S.
Drugs Fut 2005, 30(10): 1047
Summary | Full Text: HTMLPDF 
 
  
  
 Recent advances in the structural modification of ligustrazine and cerebro/cardiovascular activity of ligustrazine derivatives.
Cheng, X.-C, Liu, X.-Y., Xu, W.-F.
Drugs Fut 2005, 30(10): 1059
Summary | Full Text: HTMLPDF 
 
  
  
 Targeted therapies directed to tumor-associated antigens.
Everts, M.
Drugs Fut 2005, 30(10): 1067
Summary | Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy